Skip to main content
Skip to content
Case File
sd-10-EFTA01392046Dept. of JusticeOther

EFTA Document EFTA01392046

GL0US144 Glenn Warren Section 1: Executive Summary Glendower Capital Secondary Opportunities Fund IV. LP • Leverages informational advantage from relationships with over 180 Fund Sponsors.25 • Conducts a rigorous value driven. asset-by-asset, bottom-up analysis focused on: — Operational. financial and market risk analysis for each underlying portfolio company — Cash flow analysis at portfolio level — Review of fund and portfolio company management — Analysis of the impact of terms an

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01392046
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

GL0US144 Glenn Warren Section 1: Executive Summary Glendower Capital Secondary Opportunities Fund IV. LP • Leverages informational advantage from relationships with over 180 Fund Sponsors.25 • Conducts a rigorous value driven. asset-by-asset, bottom-up analysis focused on: — Operational. financial and market risk analysis for each underlying portfolio company — Cash flow analysis at portfolio level — Review of fund and portfolio company management — Analysis of the impact of terms an

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GL0US144 Glenn Warren Section 1: Executive Summary Glendower Capital Secondary Opportunities Fund IV. LP Leverages informational advantage from relationships with over 180 Fund Sponsors.25 Conducts a rigorous value driven. asset-by-asset, bottom-up analysis focused on: Operational. financial and market risk analysis for each underlying portfolio company Cash flow analysis at portfolio level Review of fund and portfolio company management Analysis of the impact of terms and structure on net returns Critical assessment of the prospects for liquidity Identifies investment opportunities where there is an alignment of interest between the Fund Sponsor arid its investors and the majority of value is in identifiable. attractive assets with reasonable leverage and attractive *see through" entry multiple at secondary pricing. Strong alignment of interests The interests of the Glendower SOF Team will be strongly aligned with the investors in the Fund: The senior members of Glendower Capital intend to commit a minimum of 1.0% of the Fund. The partners and professionals of Glendower Capital will be entitled to receive all the Carried Interest generated by the Fund. The Investment Committee of the Fund will consist solely of individuals from Glendower Capital. Deutsche Bank will not be involved in the management of SOF IV. or any future funds managed or advised by Glendower Capital. Accordingly. Deutsche Bank will not receive any carried interest or general partners share (or the equivalent thereof) generated by SOF IV. The key terms of the Fund are highlighted in Section 3: Summary of Principal Terms and set out in more detail in Section 6: Summary of Terms and Conditions. Certain risks and potential conflicts of interest associated with the Fund are highlighted in Section 7: Risk Factors and Section 8: Conflicts of Interests which Investors should consider carefully. Source. Glendower Capital s propnewy inlormeecn To tne extent that such Information s avastatle Confidential Private Placement Memorandum 6 CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0097195 CONFIDENTIAL SDNY_GM_00243379 EFTA01392046

Related Documents (6)

Dept. of JusticeOtherUnknown

EFTA Document EFTA01443401

GLDUS144 Glenn Warren GLENDOWER ACCESS SECONDARY OPPORTUNITIES FUND IV (U.S.), L.P. CONFIDENTIAL Glendower Access Secondary Opportunities IV (U.S.), L.P. will invest substantially all of its investable assets into Glendower Capital Secondary Opportunities Fund IV, L.P. (the "Underlying Fund"). ACCESS & UNDERLYING FUND TERMS ACCESS FUND GLENDOWER ACCESS SECONDARY OPPORTUNITIES IV (U.S.), L.P. GENERAL PARTNER Glendower Access Secondary Opportunities IV GP, LLC INVESTMENT MANAGER iCap

40p
Dept. of JusticeMar 11, 2011

FBI USAMRID Investigation

011621Anthrax Page 1 of 1446 o I 2792\-WF-222936-'-USAMRIID - \\OC o I [he followijg investigation was conducted by Special Agent (SA)_ _of the federal Bureau of Investigation (FBI) on February 24, 2005: ? The United States Army Medical Research Institute of Infectious Diseases (USAMRIID) Keycard Access records from 1998 through 2002 were queried f r v' ? ? ? scientist nd visitin scient'st both ?rom the who have p eviously been identified as visiting USAMRIID circa May 1998. ;11 available

1446p
Dept. of JusticeAug 22, 2017

15 July 7 2016 - July 17 2016 working progress_Redacted.pdf

Kristen M. Simkins From: Sent: To: Cc: Subject: Irons, Janet < Tuesday, July 12, 2016 10:47 AM Richard C. Smith     Hello Warden Smith,     mother is anxious to hear the results of your inquiry into her daughter's health.   I'd be grateful if you could  email or call me at your earliest convenience.  I'm free today after 2 p.m.  Alternatively, we could meet after the Prison  Board of Inspectors Meeting this coming Thursday.    Best wishes,    Janet Irons    1 Kristen M. Simkins From: Sent:

1196p
OtherUnknown

:ate: 7/19/06

DOJ EFTA Data Set 10 document EFTA01333133

88p
Dept. of JusticeAug 22, 2017

1 May 1 1255-May 6 237_Redacted.pdf

Kristen M. Simkins me: Sent Tn: Subject: Atladimem: LT. THOMAS E. ALLEN JR Thomas S. Allen. Jr. Sunday. May BIL EDIE 12:55 AM Allyson FL Dwell; Brenda McKin1e?c C. Kay Wandring: Caitlyn D. Neff: Daniel?le Minarch?lck: JeFFrey' T. Hite; Jon D. Fisher. Jonathan M. Mfl?n-der. Joseph 5. Kolenorluan Mendez: Kevin T. Jeirles; [any Lidgett Lee R. Shea??er: Lorinda L. Brown.- Matti-new T. Fishet: Melanie Gordan; Michael S. Woods Richard C. 5mm; Shephanie D. Calander?mtus Report SMDIE 20150501004

493p
Dept. of JusticeMar 24, 2022

Trump lawsuit

3/24/22

108p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.